alizarin has been researched along with Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
Han, JM; Jung, HJ; Nguyen, TTH; Pandey, RP; Park, YI; Sohng, JK | 1 |
AVIAD, I; SCHORR, S | 1 |
AVIAD, I; LAUFER, A; SCHORR, S | 1 |
2 review(s) available for alizarin and Neoplasms
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
3 other study(ies) available for alizarin and Neoplasms
Article | Year |
---|---|
Regio-specific biotransformation of alizarin to alizarin methoxide with enhanced cytotoxicity against proliferative cells.
Topics: Anthraquinones; Antineoplastic Agents; Biotransformation; Cell Line, Tumor; Cell Proliferation; Escherichia coli; HeLa Cells; Hep G2 Cells; Humans; Industrial Microbiology; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Neoplasms; Streptomyces | 2020 |
[In-vivo staining with alizarin in malignant conditions of bone].
Topics: Anthraquinones; Bone and Bones; Bone Neoplasms; Coloring Agents; Neoplasms; Staining and Labeling | 1959 |
Vital staining with alizarin in clinical malignant conditions of bone.
Topics: Anthraquinones; Bone and Bones; Bone Neoplasms; Coloring Agents; Neoplasms; Staining and Labeling | 1959 |